Mosquito-borne viral encephalitis

Summary

Mosquito-borne viral encephalitis (MONDO:0020601) is a disease (an umbrella term covering 5 Mondo subtypes). A subtype of viral encephalitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 5 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mosquito-borne viral encephalitis
Mondo ID	MONDO:0020601
ICD-10-CM	A83
NCIT	C34823
UMLS	C0751098
MedGen	152945
GARD	0025184
Is cancer (heuristic)	no

Also known as: mosquito-borne viral encephalitis

Disease family

This is a subtype of viral encephalitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › encephalomyelitis › encephalitis › infectious encephalitis › viral encephalitis › mosquito-borne viral encephalitis

Related subtypes (11): Powassan encephalitis, acute necrotizing encephalitis, acute hemorrhagic encephalitis, Colorado tick fever, eastern equine encephalitis, subacute sclerosing panencephalitis, herpes simplex encephalitis, tick-borne encephalitis, encephalitis lethargica, HHV-6 encephalitis, borna virus encephalitis

Subtypes (5): st. Louis encephalitis, Japanese encephalitis, West-Nile encephalitis, la Crosse encephalitis, western equine encephalitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.